ARMCX1
gene geneOn this page
Also known as ALEX1GASP7
Summary
ARMCX1 (armadillo repeat containing X-linked 1, HGNC:18073) is a protein-coding gene on chromosome Xq22.1, encoding Armadillo repeat-containing X-linked protein 1 (Q9P291). Regulates mitochondrial transport during axon regeneration.
This gene encodes a member of the ALEX family of proteins and may play a role in tumor suppression. The encoded protein contains a potential N-terminal transmembrane domain and two Armadillo (arm) repeats. Other proteins containing the arm repeat are involved in development, maintenance of tissue integrity, and tumorigenesis. This gene is closely localized with other family members, including ALEX2 and ALEX3, on the X chromosome.
Source: NCBI Gene 51309 — RefSeq curated summary.
At a glance
- Clinical variants (ClinVar): 58 total — 3 pathogenic
- MANE Select transcript:
NM_016608
Identifiers
Gene identifiers
| Field | Value |
|---|---|
| HGNC ID | HGNC:18073 |
| Approved symbol | ARMCX1 |
| Name | armadillo repeat containing X-linked 1 |
| Location | Xq22.1 |
| Locus type | gene with protein product |
| Status | Approved |
| Aliases | ALEX1, GASP7 |
| Ensembl gene | ENSG00000126947 |
| Ensembl biotype | protein_coding |
| OMIM | 300362 |
| Entrez | 51309 |
Gene structure
Transcript identifiers
Ensembl transcripts: 31 — 31 protein_coding
ENST00000372829, ENST00000898854, ENST00000898855, ENST00000898856, ENST00000898857, ENST00000898858, ENST00000898859, ENST00000898860, ENST00000898861, ENST00000898862, ENST00000898863, ENST00000898864, ENST00000898865, ENST00000936538, ENST00000936539, ENST00000936540, ENST00000936541, ENST00000936542, ENST00000936543, ENST00000936544, ENST00000936545, ENST00000936546, ENST00000936547, ENST00000936548, ENST00000964328, ENST00000964329, ENST00000964330, ENST00000964331, ENST00000964332, ENST00000964333, ENST00000964334
RefSeq mRNA: 1 — MANE Select: NM_016608
NM_016608
CCDS: CCDS14487
Canonical transcript exons
ENST00000372829 — 4 exons
| Exon | Start | End |
|---|---|---|
| ENSE00001032388 | 101551569 | 101551633 |
| ENSE00001032390 | 101550547 | 101550660 |
| ENSE00001032391 | 101550971 | 101551024 |
| ENSE00001458756 | 101552809 | 101554700 |
Expression profiles
Bgee: expression breadth ubiquitous, 284 present calls, max score 98.52.
FANTOM5 (CAGE): breadth ubiquitous, TPM avg 22.8695 / max 240.7400, expressed in 1527 samples.
FANTOM5 promoters (3 alternative TSS)
| Promoter ID | TPM avg | Samples expressed |
|---|---|---|
| 196964 | 14.1680 | 1506 |
| 196965 | 6.2925 | 1398 |
| 196963 | 2.4089 | 1180 |
Top tissues by expression
286 total, by Bgee expression score (0-100, higher = more expressed):
| Tissue | Anatomy ID | Expression score | Quality |
|---|---|---|---|
| germinal epithelium of ovary | UBERON:0001304 | 98.52 | gold quality |
| choroid plexus epithelium | UBERON:0003911 | 97.91 | gold quality |
| parietal pleura | UBERON:0002400 | 97.88 | gold quality |
| Brodmann (1909) area 23 | UBERON:0013554 | 97.37 | gold quality |
| heart right ventricle | UBERON:0002080 | 96.65 | gold quality |
| pleura | UBERON:0000977 | 96.63 | gold quality |
| cartilage tissue | UBERON:0002418 | 96.15 | gold quality |
| visceral pleura | UBERON:0002401 | 95.66 | gold quality |
| cauda epididymis | UBERON:0004360 | 95.64 | gold quality |
| skeletal muscle tissue of rectus abdominis | UBERON:0004511 | 95.52 | gold quality |
| renal glomerulus | UBERON:0000074 | 95.46 | gold quality |
| blood vessel layer | UBERON:0004797 | 95.40 | gold quality |
| metanephric glomerulus | UBERON:0004736 | 95.26 | gold quality |
| myocardium | UBERON:0002349 | 95.24 | gold quality |
| seminal vesicle | UBERON:0000998 | 95.17 | gold quality |
| biceps brachii | UBERON:0001507 | 95.17 | gold quality |
| corpus epididymis | UBERON:0004359 | 95.05 | gold quality |
| mammary duct | UBERON:0001765 | 95.04 | gold quality |
| synovial joint | UBERON:0002217 | 95.01 | gold quality |
| cortical plate | UBERON:0005343 | 94.99 | gold quality |
| skeletal muscle tissue of biceps brachii | UBERON:0004502 | 94.89 | gold quality |
| epithelium of mammary gland | UBERON:0003244 | 94.79 | gold quality |
| hair follicle | UBERON:0002073 | 94.57 | gold quality |
| middle temporal gyrus | UBERON:0002771 | 94.57 | gold quality |
| amniotic fluid | UBERON:0000173 | 94.52 | gold quality |
| urethra | UBERON:0000057 | 94.27 | gold quality |
| cardiac muscle of right atrium | UBERON:0003379 | 94.27 | gold quality |
| calcaneal tendon | UBERON:0003701 | 94.27 | gold quality |
| skin of hip | UBERON:0001554 | 94.23 | gold quality |
| caput epididymis | UBERON:0004358 | 94.18 | gold quality |
Single-cell (SCXA)
Detected in 2 experiment(s), a significant marker in 2.
| Experiment | Marker? | Max mean expression |
|---|---|---|
| E-ANND-3 | yes | 10.54 |
| E-CURD-112 | yes | 4.48 |
Regulation
Is transcription factor: no
Upstream regulators (CollecTRI, top): CREB1
miRNA regulators (miRDB)
37 targeting ARMCX1, top 30 by miRDB confidence (max_score; target_count = how many genes the miRNA targets in total — lower means more specific):
| miRNA | Max score | Avg score | miRNA target_count |
|---|---|---|---|
| HSA-MIR-6740-5P | 100.00 | 65.64 | 932 |
| HSA-MIR-223-3P | 99.99 | 70.14 | 1140 |
| HSA-MIR-548C-3P | 99.99 | 74.01 | 7587 |
| HSA-LET-7C-3P | 99.95 | 73.42 | 2862 |
| HSA-MIR-7-1-3P | 99.91 | 71.53 | 4384 |
| HSA-MIR-7-2-3P | 99.91 | 71.40 | 4394 |
| HSA-MIR-95-5P | 99.89 | 72.17 | 3973 |
| HSA-MIR-548AZ-5P | 99.83 | 69.94 | 3230 |
| HSA-MIR-548T-5P | 99.83 | 69.91 | 3220 |
| HSA-MIR-3913-5P | 99.78 | 67.26 | 968 |
| HSA-MIR-8084 | 99.73 | 69.57 | 1760 |
| HSA-MIR-1208 | 99.70 | 68.28 | 1533 |
| HSA-MIR-646 | 99.68 | 67.84 | 1645 |
| HSA-MIR-3177-5P | 99.65 | 70.38 | 1174 |
| HSA-MIR-586 | 99.65 | 70.40 | 2051 |
| HSA-MIR-885-5P | 99.59 | 68.59 | 879 |
| HSA-MIR-4524A-5P | 99.57 | 71.73 | 1193 |
| HSA-MIR-4524B-5P | 99.57 | 71.68 | 1195 |
| HSA-MIR-3122 | 99.50 | 66.33 | 821 |
| HSA-MIR-216A-5P | 99.50 | 68.02 | 1288 |
| HSA-MIR-21-5P | 99.46 | 70.54 | 1035 |
| HSA-MIR-16-2-3P | 99.29 | 70.60 | 1954 |
| HSA-MIR-195-3P | 99.29 | 70.61 | 1954 |
| HSA-MIR-590-5P | 99.25 | 70.76 | 930 |
| HSA-MIR-6071 | 99.16 | 67.77 | 1780 |
| HSA-MIR-3125 | 99.14 | 68.49 | 2269 |
| HSA-MIR-3916 | 98.99 | 68.04 | 2155 |
| HSA-MIR-6859-5P | 98.99 | 68.07 | 2049 |
| HSA-MIR-4704-3P | 98.28 | 69.33 | 1300 |
| HSA-MIR-6831-5P | 98.26 | 67.20 | 990 |
Literature-anchored findings (GeneRIF, showing 8)
- Human Arm protein lost in epithelial cancers, on chromosome X 1 (ALEX1) gene is transcriptionally regulated by CREB and Wnt/beta-catenin signaling. (PMID:20398052)
- Findings suggest that overexpression of ALEX1 (armadillo repeat containing, X-linked [ARMCX]) plays a negative role in colorectal tumorigenesis. (PMID:22494058)
- ALEX1 is a crucial tumor suppressor gene involved in cell proliferation and apoptosis in breast cancer. (PMID:25921134)
- It is suggested that the ALEX1 protein is associated with tumorigenesis in cervical cancer and we speculate that the ALEX1 may plays a role as an oncogene in cervical cancer. (PMID:26464700)
- ALEX1 expression is reduced in gastric cancer; ALEX1 inhibits metastasis through the PAR-1/Rho GTPase signaling pathway. (PMID:28315004)
- Up-regulation of ALEX1 effectively rescued the cell apoptosis induced by miR-106b inhibitor and promoted the expression levels of phosphorylation of JAK1 and STAT3. (PMID:30907988)
- ARMCX Family Gene Expression Analysis and Potential Prognostic Biomarkers for Prediction of Clinical Outcome in Patients with Gastric Carcinoma. (PMID:32685472)
- The Expression of ARMCX1 in Gastric Cancer Contributes to Prognosis and Influences Chemotherapy. (PMID:36726491)
Cross-species orthologs
4 orthologs
| Organism | Symbol | Gene ID |
|---|---|---|
| danio_rerio | armc10 | ENSDARG00000062960 |
| mus_musculus | Armcx1 | ENSMUSG00000033460 |
| rattus_norvegicus | Armcx1 | ENSRNOG00000046862 |
| caenorhabditis_elegans | WBGENE00013456 |
Paralogs (10): ARMCX3 (ENSG00000102401), ARMCX5 (ENSG00000125962), ARMC12 (ENSG00000157343), GPRASP2 (ENSG00000158301), ARMC10 (ENSG00000170632), ARMCX2 (ENSG00000184867), ARMCX4 (ENSG00000196440), GPRASP3 (ENSG00000198908), GPRASP1 (ENSG00000198932), ARMCX6 (ENSG00000198960)
Protein
Protein identifiers
Armadillo repeat-containing X-linked protein 1 — Q9P291 (reviewed: Q9P291)
Alternative names: ARM protein lost in epithelial cancers on chromosome X 1
All UniProt accessions (1): Q9P291
UniProt curated annotations — full annotation on UniProt →
Function. Regulates mitochondrial transport during axon regeneration. Increases the proportion of motile mitochondria by recruiting stationary mitochondria into the motile pool. Enhances mitochondria movement and neurite growth in both adult axons and embryonic neurons. Promotes neuronal survival and axon regeneration after nerve injury. May link mitochondria to the Trak1-kinesin motor complex via its interaction with MIRO1.
Subunit / interactions. Interacts with MIRO1.
Subcellular location. Mitochondrion. Mitochondrion outer membrane.
Tissue specificity. Expressed at high levels ovary, heart, testis, prostate, brain, spleen and colon. Expressed at very low levels in liver and thymus. Not expressed in peripheral blood leukocytes. Not or reduced expressed in lung, prostate, colon, pancreas and ovarian carcinomas.
Similarity. Belongs to the eutherian X-chromosome-specific Armcx family.
RefSeq proteins (1): NP_057692* (*=MANE)
Domains & families (InterPro)
| ID | Name | Type |
|---|---|---|
| IPR000225 | Armadillo | Repeat |
| IPR006911 | ARM-rpt_dom | Domain |
| IPR011989 | ARM-like | Homologous_superfamily |
| IPR016024 | ARM-type_fold | Homologous_superfamily |
| IPR051303 | Armcx_regulator | Family |
Pfam: PF04826
UniProt features (15 total): region of interest 4, repeat 4, topological domain 2, sequence conflict 2, chain 1, compositionally biased region 1, transmembrane region 1
Structure
Experimental structures (PDB)
0 structures.
Predicted structure (AlphaFold)
| Model | pLDDT | Fraction very-high |
|---|---|---|
| AF-Q9P291-F1 | 74.28 | 0.56 |
Function
Pathways and Gene Ontology
Reactome pathways
0 pathways
MSigDB gene sets: 175 (showing top):
GSE45365_CD8A_DC_VS_CD11B_DC_IFNAR_KO_MCMV_INFECTION_UP, GSE18804_SPLEEN_MACROPHAGE_VS_BRAIN_TUMORAL_MACROPHAGE_DN, WAMUNYOKOLI_OVARIAN_CANCER_LMP_DN, GOBP_AXO_DENDRITIC_TRANSPORT, GRAESSMANN_APOPTOSIS_BY_DOXORUBICIN_DN, GRAESSMANN_RESPONSE_TO_MC_AND_DOXORUBICIN_DN, GOBP_ORGANELLE_TRANSPORT_ALONG_MICROTUBULE, CHANDRAN_METASTASIS_DN, MOLENAAR_TARGETS_OF_CCND1_AND_CDK4_UP, CREIGHTON_ENDOCRINE_THERAPY_RESISTANCE_1, AML_Q6, GOCC_MITOCHONDRIAL_ENVELOPE, DOUGLAS_BMI1_TARGETS_DN, GOBP_MULTICELLULAR_ORGANISMAL_LEVEL_HOMEOSTASIS, GOCC_NEURON_PROJECTION
GO Biological Process (1): hematopoietic stem cell homeostasis (GO:0061484)
GO Molecular Function (1): protein binding (GO:0005515)
GO Cellular Component (3): mitochondrion (GO:0005739), mitochondrial outer membrane (GO:0005741), membrane (GO:0016020)
GO top-level categories
Rollup of top GO terms by namespace:
| Category | Terms |
|---|---|
| homeostasis of number of cells | 1 |
| binding | 1 |
| cytoplasm | 1 |
| intracellular membrane-bounded organelle | 1 |
| mitochondrial membrane | 1 |
| organelle outer membrane | 1 |
| cellular anatomical structure | 1 |
Protein interactions and networks
STRING
1059 interactions, top by confidence (×1000):
| Protein A | Protein B | Partner UniProt | Score |
|---|---|---|---|
| ARMCX1 | SPTAN1 | Q13813 | 650 |
| ARMCX1 | RHOT1 | Q8IXI2 | 630 |
| ARMCX1 | SNPH | O15079 | 597 |
| ARMCX1 | RB1 | P06400 | 549 |
| ARMCX1 | TRAK2 | O60296 | 548 |
| ARMCX1 | GPSM1 | Q86YR5 | 441 |
| ARMCX1 | WDR49 | Q8IV35 | 407 |
| ARMCX1 | KIF5C | O60282 | 389 |
| ARMCX1 | KIFC3 | Q9BVG8 | 373 |
| ARMCX1 | CRISPLD1 | Q9H336 | 359 |
| ARMCX1 | FSTL5 | Q8N475 | 343 |
| ARMCX1 | PLS3 | P13797 | 329 |
| ARMCX1 | GPSM2 | P81274 | 318 |
| ARMCX1 | TRAK1 | Q9UPV9 | 314 |
| ARMCX1 | ZBBX | A8MT70 | 312 |
IntAct
31 interactions, top by confidence:
| A | B | Type | Score |
|---|---|---|---|
| ARMCX1 | ZBTB8A | psi-mi:“MI:0915”(physical association) | 0.720 |
| ZBTB8A | ARMCX1 | psi-mi:“MI:0915”(physical association) | 0.720 |
| TFIP11 | ARMCX1 | psi-mi:“MI:0915”(physical association) | 0.670 |
| ARMCX1 | TFIP11 | psi-mi:“MI:0915”(physical association) | 0.670 |
| ARMCX1 | COIL | psi-mi:“MI:0915”(physical association) | 0.560 |
| COIL | ARMCX1 | psi-mi:“MI:0915”(physical association) | 0.560 |
| GPKOW | ARMCX1 | psi-mi:“MI:0915”(physical association) | 0.560 |
| PICK1 | ARMCX1 | psi-mi:“MI:0915”(physical association) | 0.560 |
| CEP70 | ARMCX1 | psi-mi:“MI:0915”(physical association) | 0.560 |
| BCAR1 | MYO1C | psi-mi:“MI:0914”(association) | 0.350 |
| FECH | POTEF | psi-mi:“MI:0914”(association) | 0.350 |
| ARMCX1 | GYG1 | psi-mi:“MI:0914”(association) | 0.350 |
| LGALS3BP | ACACB | psi-mi:“MI:0914”(association) | 0.350 |
| PPARD | LRP6 | psi-mi:“MI:0914”(association) | 0.350 |
| GATA2 | C11orf98 | psi-mi:“MI:0914”(association) | 0.350 |
| CDH5 | ESYT2 | psi-mi:“MI:2364”(proximity) | 0.270 |
| ARMCX1 | ZBTB8A | psi-mi:“MI:0915”(physical association) | 0.000 |
| ARMCX1 | PICK1 | psi-mi:“MI:0915”(physical association) | 0.000 |
| ARMCX1 | CEP70 | psi-mi:“MI:0915”(physical association) | 0.000 |
| ARMCX1 | psi-mi:“MI:0915”(physical association) | 0.000 |
BioGRID (15): ARMCX1 (Two-hybrid), ARMCX1 (Two-hybrid), ZBTB8A (Two-hybrid), ARMCX1 (Affinity Capture-MS), ARMCX1 (Affinity Capture-MS), ARMCX1 (Affinity Capture-MS), ARMCX1 (Affinity Capture-MS), ARMCX1 (Positive Genetic), ARMCX1 (Two-hybrid), ARMCX1 (Two-hybrid), ARMCX1 (Two-hybrid), ZBTB8A (Two-hybrid), ARMCX1 (Affinity Capture-MS), SPC25 (Cross-Linking-MS (XL-MS)), ARMCX1 (Cross-Linking-MS (XL-MS))
ESM2 similar proteins: A0A0M3U1B0, A1A5Q6, A2AFS9, A2AVR2, A2CI98, A2CJ06, A2RTY3, A2RUW0, O70167, O70173, P0C2Y1, P15304, P59729, Q08EC4, Q3SYK4, Q3TYG6, Q3U1D0, Q4R744, Q4R9E9, Q5R4B2, Q5T4T6, Q5TGP6, Q5VWK0, Q68CQ1, Q6AYJ3, Q6IFT4, Q6IRU7, Q6REY9, Q6ZUA9, Q7Z572, Q80VH0, Q86WZ0, Q86XG9, Q8C0X8, Q8CCC3, Q8ND61, Q8NDZ2, Q8TB24, Q96M43, Q96QP1
Diamond homologs: B1WBW4, Q3UZB0, Q5H9R4, Q5JY77, Q5R4B2, Q5R7U0, Q5R9J3, Q5RDG2, Q5U310, Q5U4C1, Q5XID7, Q6A058, Q6P1M9, Q6PI77, Q7L311, Q8BHS6, Q8BUY8, Q8N2F6, Q920R4, Q96D09, Q9BE11, Q9CX83, Q9D0L7, Q9P291, Q9UH62, Q6PB60, Q71HP2, Q66HF0, Q7L4S7, Q8K3A6
SIGNOR signaling
0 interactions.
Disease & clinical
Clinical variants and AI predictions
ClinVar
58 variants total. Per-class counts are floors (≥ shown; pagination cap):
| Classification | Count (floor) |
|---|---|
| Pathogenic | 3 |
| Likely pathogenic | 0 |
| Uncertain significance | 32 |
| Likely benign | 3 |
| Benign | 1 |
Top pathogenic / likely-pathogenic (3)
| Variant ID | HGVS | Classification |
|---|---|---|
| 3024654 | GRCh37/hg19 Xq12-28(chrX:67292994-155240074)x3 | Pathogenic |
| 57972 | GRCh38/hg38 Xq22.1(chrX:101323599-101596196)x1 | Pathogenic |
| 57973 | GRCh38/hg38 Xq22.1-22.3(chrX:101407698-106274188)x1 | Pathogenic |
SpliceAI
796 predictions. Top by Δscore:
| Variant | Effect | Δscore |
|---|---|---|
| X:101551634:G:GG | donor_gain | 1.0000 |
| X:101550657:GCAG:G | donor_gain | 0.9800 |
| X:101550969:A:AG | acceptor_gain | 0.9800 |
| X:101550969:AGTAG:A | acceptor_gain | 0.9800 |
| X:101550970:G:GG | acceptor_gain | 0.9800 |
| X:101550970:GTA:G | acceptor_gain | 0.9800 |
| X:101550970:GTAGG:G | acceptor_gain | 0.9800 |
| X:101552548:G:GT | donor_gain | 0.9800 |
| X:101552803:TCCTA:T | acceptor_loss | 0.9800 |
| X:101552804:CCTA:C | acceptor_loss | 0.9800 |
| X:101552805:CTAGG:C | acceptor_loss | 0.9800 |
| X:101552806:TA:T | acceptor_loss | 0.9800 |
| X:101552807:A:AC | acceptor_loss | 0.9800 |
| X:101552808:G:A | acceptor_loss | 0.9800 |
| X:101550656:AGCAG:A | donor_loss | 0.9700 |
| X:101550657:GCAGG:G | donor_loss | 0.9700 |
| X:101550658:CAGG:C | donor_loss | 0.9700 |
| X:101550659:AG:A | donor_loss | 0.9700 |
| X:101550660:G:GC | donor_loss | 0.9700 |
| X:101550661:G:A | donor_loss | 0.9700 |
| X:101550662:T:G | donor_loss | 0.9700 |
| X:101550730:G:GT | donor_gain | 0.9700 |
| X:101550970:GT:G | acceptor_gain | 0.9700 |
| X:101551156:G:GT | donor_gain | 0.9700 |
| X:101551634:GTA:G | donor_loss | 0.9700 |
| X:101551635:TAG:T | donor_loss | 0.9700 |
| X:101553057:GAGTC:G | donor_gain | 0.9700 |
| X:101551021:GCAGG:G | donor_loss | 0.9600 |
| X:101551022:CAG:C | donor_loss | 0.9600 |
| X:101551023:AGG:A | donor_loss | 0.9600 |
AlphaMissense
2968 scored. Top likely-pathogenic:
| Variant | Protein change | am_pathogenicity |
|---|---|---|
| X:101553753:A:C | S275R | 1.000 |
| X:101553755:T:A | S275R | 1.000 |
| X:101553755:T:G | S275R | 1.000 |
| X:101553852:G:T | G308W | 1.000 |
| X:101553550:T:C | L207P | 0.999 |
| X:101553571:T:C | L214P | 0.999 |
| X:101553607:C:A | A226D | 0.999 |
| X:101553610:T:G | L227W | 0.999 |
| X:101553619:T:C | L230P | 0.999 |
| X:101553622:G:A | G231D | 0.999 |
| X:101553630:G:C | A234P | 0.999 |
| X:101553631:C:A | A234E | 0.999 |
| X:101553658:T:A | I243K | 0.999 |
| X:101553658:T:G | I243R | 0.999 |
| X:101553661:G:C | R244P | 0.999 |
| X:101553738:G:C | A270P | 0.999 |
| X:101553742:T:A | L271H | 0.999 |
| X:101553742:T:C | L271P | 0.999 |
| X:101553746:T:A | N272K | 0.999 |
| X:101553746:T:G | N272K | 0.999 |
| X:101553749:C:A | N273K | 0.999 |
| X:101553749:C:G | N273K | 0.999 |
| X:101553751:T:C | L274S | 0.999 |
| X:101553770:T:A | N280K | 0.999 |
| X:101553770:T:G | N280K | 0.999 |
| X:101553852:G:A | G308R | 0.999 |
| X:101553852:G:C | G308R | 0.999 |
| X:101553856:T:C | L309P | 0.999 |
| X:101553862:T:C | L311P | 0.999 |
| X:101553872:C:A | N314K | 0.999 |
dbSNP variants (sampled 300 via entrez): RS1000683827 (X:101552196 A>G), RS1000709469 (X:101554625 A>G), RS1001011875 (X:101552493 A>C), RS1001442610 (X:101554230 C>T), RS1001512758 (X:101553492 C>T), RS1001846295 (X:101551290 G>C), RS1003447312 (X:101549895 A>G), RS1005199331 (X:101552999 T>C), RS1006801754 (X:101551244 T>C), RS1007632718 (X:101550435 G>C), RS1010907360 (X:101549937 G>C), RS1011399911 (X:101549388 T>C), RS1016586231 (X:101550633 G>A), RS1017345805 (X:101552508 G>T), RS1019022758 (X:101550436 G>A)
Disease associations
OMIM: gene MIM:300362 | disease phenotypes:
GenCC curated gene-disease
Mondo (0):
Orphanet (0):
HPO phenotypes
0 total (0 of 0 shown, HPO-id order):
GWAS associations
0 associations (top):
Drugs & pharmacology
Drug and pharmacology data
Is drug target: no
PharmGKB: 1 entry (VIP=true, CPIC=false)
CTD chemical–gene interactions
44 total (human), top 30 by PubMed support.
| Chemical | Actions (top 5) | PubMed papers |
|---|---|---|
| Valproic Acid | affects expression, decreases expression, increases expression | 4 |
| sodium arsenite | decreases expression, affects methylation | 3 |
| Silicon Dioxide | increases expression | 3 |
| bisphenol A | increases expression, affects cotreatment | 2 |
| Indomethacin | decreases expression, affects cotreatment, increases expression | 2 |
| Phenylmercuric Acetate | affects cotreatment, decreases expression | 2 |
| Cyclosporine | decreases expression, increases expression | 2 |
| Particulate Matter | increases abundance, affects cotreatment, decreases expression | 2 |
| aristolochic acid I | increases expression | 1 |
| TAK-243 | increases sumoylation | 1 |
| dodecyldimethylamine oxide | increases expression | 1 |
| arsenite | increases methylation | 1 |
| butyraldehyde | increases expression | 1 |
| zinc chromate | increases abundance, increases expression | 1 |
| nickel sulfate | decreases expression | 1 |
| chromium hexavalent ion | increases abundance, increases expression | 1 |
| perfluorooctane sulfonic acid | increases expression | 1 |
| 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide | decreases expression, affects cotreatment | 1 |
| nutlin 3 | affects cotreatment, increases expression | 1 |
| abrine | increases expression | 1 |
| dorsomorphin | affects cotreatment, decreases expression | 1 |
| 2-(1H-indazol-4-yl)-6-(4-methanesulfonylpiperazin-1-ylmethyl)-4-morpholin-4-ylthieno(3,2-d)pyrimidine | increases response to substance, increases expression | 1 |
| Temozolomide | decreases expression | 1 |
| Sunitinib | decreases expression | 1 |
| Acetaminophen | increases expression | 1 |
| Air Pollutants | decreases expression, increases abundance | 1 |
| Ethanol | affects cotreatment, decreases expression, increases abundance | 1 |
| Benzo(a)pyrene | affects methylation, decreases methylation | 1 |
| Camptothecin | increases expression | 1 |
| Dactinomycin | affects cotreatment, increases expression | 1 |
Clinical trials (associated diseases)
0 trials via MONDO — disease-level, not drug-specific.
Related Atlas pages
No linked Atlas pages yet — the cross-entity mesh grows as the corpus expands.